Amylin (AMLN) has apparently attracted interest from potential suitors including Pfizer (PFE),...

|By:, SA News Editor

Amylin (AMLN) has apparently attracted interest from potential suitors including Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers (BMY) and Sanofi (SNY), all of which have signed confidentiality agreements on the drugmaker's sale process. Sources say first-round bids are due in the next two weeks.